ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.
Advertisement
The Scientist
Most Recent
Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
Industry experts discuss the agency’s plans to make the drug approval process more transparent.
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of d
Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. Techniques for delivering the corrective payload vary widely. Many gene therapies utilize modif
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
